Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Deregulated expression of A1, Bcl-2, Bcl-x(L), and Mcl-1 antiapoptotic proteins and Bid, Bad, and Bax proapoptotic genes in polycythemia vera patients

Texto completo
Autor(es):
Mostrar menos -
Lino Gasparotto, Elainy Patricia [1] ; Tognon, Raquel [1] ; Ferreira, Aline Fernanda [1] ; Vilela Oliveira, Gislane Lelis [1] ; Bonini Palma, Patricia Vianna [2] ; Zanichelli, Maria Aparecida [3] ; Souto, Elizabeth Xisto [3] ; Engel Velano, Carlos Eduardo [4] ; Simoes, Belinda Pinto [4] ; Viu Carrara, Rita de Cassia [2] ; Kashima, Simone [2] ; Covas, Dimas Tadeu [2, 4] ; de Castro, Fabiola Attie [1] ; de Souza, Ana Maria [1]
Número total de Autores: 14
Afiliação do(s) autor(es):
[1] USP, Dept Clin Anal Toxicol & Food Sci, Fac Pharmaceut Sci Ribeirao Preto, BR-14040903 Ribeirao Preto, SP - Brazil
[2] USP, Hemotherapy Ctr Ribeirao Preto, Sch Med Ribeirao Preto, BR-14040903 Ribeirao Preto, SP - Brazil
[3] Brigadeiro Hosp, Sao Paulo - Brazil
[4] USP, Dept Clin Med, Fac Med Ribeirao Preto, BR-14040903 Ribeirao Preto, SP - Brazil
Número total de Afiliações: 4
Tipo de documento: Artigo Científico
Fonte: Brazilian Journal of Pharmaceutical Sciences; v. 47, n. 4, p. 873-886, OCT-DEC 2011.
Citações Web of Science: 6
Resumo

Apoptosis deregulation might have a role in the pathophysiology of polycythemia vera (PV). This study evaluated Bcl-2 molecule expression in CD34(+) cells and leukocytes in 12 PV patients. Gene expression was investigated by real time PCR using SybrGreen Quantitect kit and protein expression was evaluated by western-blotting. JAK2 V617F mutation was detected according to Baxter et al (2005). CD34(+) cells from PV patients presented higher levels of A1 and Mc1-1 expression (median: 22.6 and 5.2, respectively) in comparison with controls (0.9 and 0.5, p=0.004 and p=0.020); while Bcl-2 and Bcl-x(L) expression decreased in PV patients (0.18 and 1.19) compared with controls (1.39 and 2.01, p=0.006 and p=0.020). CD34(+) cells in PV patients showed an elevated Bid expression (14.4) in comparison with healthy subjects (1.0; p=0.002). Patients' leukocytes showed an A1 augmentation (7.41, p=0.001) and a reduced expression of Bar (0.19; p=0.040) and Bad (0.2; p=0.030). There was no correlation between JAK2 V617F allele burden and molecular expression. PV patients showed alterations in Bcl-2 members' expression, which may interfere with control of apoptotic machinery and contribute to disease pathogenesis. (AU)

Processo FAPESP: 06/50094-8 - Expressão de gênese de proteínas pró e antiapoptóticas em doenças mieloproliferativas crônicas
Beneficiário:Fabíola Attié de Castro
Linha de fomento: Auxílio à Pesquisa - Apoio a Jovens Pesquisadores